Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
LSD
amphetamine Hallucinogen |
| gptkbp:CASNumber |
1354631-77-6
|
| gptkbp:category |
recreational drug
|
| gptkbp:chemicalFormula |
C18H24N2O
|
| gptkbp:discoveredBy |
2010s
|
| https://www.w3.org/2000/01/rdf-schema#label |
25N-NBOMe
|
| gptkbp:IUPACName |
2-(4-ethyl-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethan-1-amine
|
| gptkbp:legalStatus |
illegal in Hungary
illegal in Sweden |
| gptkbp:mechanismOfAction |
5-HT2A receptor agonist
|
| gptkbp:molecularWeight |
284.4 g/mol
|
| gptkbp:otherName |
2C-N-NBOMe
NBOMe-2C-N |
| gptkbp:relatedTo |
gptkb:25B-NBOMe
gptkb:25C-NBOMe gptkb:25I-NBOMe |
| gptkbp:routeOfAdministration |
oral
sublingual buccal |
| gptkbp:bfsParent |
gptkb:NBOMe_series
|
| gptkbp:bfsLayer |
7
|